今日热点导览 TOP 3 大新闻 大批中成药将退出市场 中成药淘汰赛序幕拉开，大批中成药将退出市场。距离2026年7月1日仅剩半年时间，国家药监局《中药 注册管理专门规定》第七十五条的落地进入最后窗口期。 这一被业内称为中成药"生死条款"的规定明确，自2023年7月1日施行满三年起，说明书【禁忌】【不良 反应】【注意事项】任意一项仍标注"尚不明确"的中成药，再注册申请将依法不予通过。这意味着，国 内现存约5.7万个中成药有效批准文号中，超70%存在安全信息标注问题的批文将面临淘汰，一场由监 管驱动的中药产业深度出清正式进入攻坚阶段。 此次监管新政的核心，是彻底终结中成药说明书长期以来的"尚不明确"时代，倒逼药品持有人补齐上市 后安全数据短板。（21世纪经济报道） 汽车行业利润率降至历史最低 乘联分会秘书长崔东树最新披露的数据显示，2025年1~12月汽车行业销售利润率降至4.1%，创下历史 新低。其中12月1.8%的利润率也创下近期低点，环比下降2.6个百分点，同比下降2.3个百分点。（第一 财经） 妙可蓝多回应"罢免"创始人 近日，妙可蓝多（600882.SH）公告称，公司创始人柴琇于1月23日被免去副董事 ...

证券研究报告|公司点评报告 [Table_Date] 2026 年 01 月 27 日 [Table_Title] 利空落地，专注经营进入新征程 [Table_Title2] 妙可蓝多(600882) | [Table_DataInfo] 评级： | 买入 | 股票代码： | 600882 | | --- | --- | --- | --- | | 上次评级： | 买入 | 52 周最高价/最低价（元)： | 32.46/17.62 | | 目标价格（元）： | | 总市值(亿元) | 116.19 | | 最新收盘价（元）： | 22.78 | 自由流通市值(亿元) | 116.19 | | | | 自由流通股数(百万) | 510.05 | [Table_Summary] 事件概述 2025 年 12 月末至今，公司发布一系列公告：12 月 27 日关于参股并购基金进展及相关风险的提示性公 告，12 月 30 日关于控股股东增持公司股份及后续增持计划的公告，1 月 26 日关于副董事长、总经理、行政总 经理离任暨聘任总经理以及变更法定代表人的公告等。 分析判断: ► 参股并购基金相关风险影响确认 2025 ...

1月25日晚，"奶酪第一股"妙可蓝多（SH600882，股价22.78元，市值116.2亿元）发布一则重要人事变 动：副董事长、总经理、法定代表人柴琇被免职，财务总监、行政总经理蒯玉龙接棒，成为新任总经理 和法定代表人。 在A股市场上，这样的免职公告并不多见，第二天（26日）妙可蓝多盘中最多跌超4%，27日收盘下跌 2.36%。 《每日经济新闻》记者注意到，在这则有关任免议案的董事会上，柴琇并未出席，也未参与投票，其任 期原本要到2027年11月。2026年1月26日，记者曾多次尝试拨打柴琇私人电话并通过微信发送采访提 纲，均未获回复。 在关于妙可蓝多的多篇公开报道中，61岁的柴琇被称为公司创始人，她去年在公开场合也多次代表公司 讲述妙可蓝多的资本故事。就在公司业绩高速增长之时，柴琇黯然离场，失去了经营权。取而代之的则 是来自控股股东内蒙古蒙牛乳业（集团）股份有限公司（以下简称内蒙蒙牛）的高管蒯玉龙，由此妙可 蓝多也全面进入"蒙牛时代"。 导火索：承诺未能兑现 这场风波源于多年前上市公司参投的一家并购基金。 2018年，妙可蓝多认缴1亿元参股了一家并购基金担任有限合伙人。这家并购基金还有一个合伙人，即 吉林省 ...

Core Viewpoint - The resignation of founder Chai Xiu from key positions at Miaokelando marks the end of the "Chai Xiu era" and signifies full control by Mengniu after the acquisition of the cheese company [1][13]. Company Changes - Chai Xiu has been removed from the positions of Vice Chairman, General Manager, and legal representative, retaining only his board member status [1][13]. - Kuai Yulong, a Mengniu executive, has been appointed as the new General Manager, indicating a shift towards a management team of younger professionals [1][13]. Historical Context - Chai Xiu founded Guangze Dairy in 2001, which became a significant player in the dairy market by 2006, capturing 90% of the local market in Jilin Province [14]. - In 2015, he pivoted the company towards cheese, launching the "Miaokelando" brand focused on children's cheese products [2][14]. - Miaokelando became the first cheese company listed on the A-share market in 2016, with revenue growing from 512 million to 1.744 billion yuan from 2016 to 2019, peaking at 5.32 billion yuan in 2023 [4][16]. Financial Issues - The direct cause of Chai Xiu's removal is linked to a long-standing arbitration dispute regarding guarantees for a private equity fund, which he failed to fulfill [5][17]. - Miaokelando reported a significant drop in net profit from 138 million yuan in 2022 to only 6 million yuan in 2023, with a projected decline in 2025 net profit due to the impact of the private equity fund [20][19]. Strategic Direction - The management change is seen as a necessary step for strategic integration under Mengniu's control, with Kuai Yulong's experience expected to enhance resource allocation and business development [1][19]. - Mengniu's resources are anticipated to provide Miaokelando with stable, low-cost raw milk, reducing reliance on imported cheese and improving cost efficiency through joint procurement [24].

近日，妙可蓝多公告称，公司创始人柴琇于1月23日被免去副董事长、总经理职务，仍然担任公司董 事，由"蒙牛系"高管蒯玉龙担任公司总经理。同时，公司法定代表人也由柴琇变更为蒯玉龙。天眼查 App显示，柴琇名下共关联10余家企业，其中5家为存续状态，包括上海妙可蓝多食品科技股份有限公 司、广泽地产集团股份有限公司等，柴琇在上述企业中担任董事长、总经理等职务，版图涉及食品、地 产、投资等。 ...

Core Viewpoint - The company Miao Ke Lan Duo has removed its founder, Chai Xiu, from key positions amid financial troubles linked to a debt issue involving a company she is associated with, leading to a significant leadership change [1][2][4]. Group 1: Leadership Change - Miao Ke Lan Duo announced the dismissal of founder Chai Xiu from her roles as vice chairman, general manager, and legal representative [1]. - The decision was made during a board meeting where Chai Xiu was absent, and the resolution was passed by the remaining eight directors [1]. - The new leadership will be taken over by the former CEO, Kuai Yulong, who has extensive experience in finance and strategy from his time at Mengniu Group [1]. Group 2: Financial Issues - The catalyst for this leadership change was a debt issue involving Jilin Yaohe, a company backed by a merger fund in which Miao Ke Lan Duo has a stake [2]. - Jilin Yaohe has defaulted on payments owed to Mengniu, leading to financial repercussions for Miao Ke Lan Duo [2]. - The investment in Jilin Yaohe is valued at approximately 129 million yuan, which is expected to reduce the company's net profit by 119 to 127 million yuan in 2025 [4]. Group 3: Ownership and Control - The ownership structure reveals that Jilin Yaohe is linked to Chai Xiu and her husband, Cui Mindong, indicating a conflict of interest [3]. - Mengniu has become the largest shareholder of Miao Ke Lan Duo, while Chai Xiu's ownership stake has decreased to 14.92% [5]. - The company has initiated arbitration against Chai Xiu regarding her previous commitment to compensate for any losses incurred by the company due to her actions [7]. Group 4: Market Context - The cheese market has shifted from a blue ocean to a red ocean, presenting new challenges for Miao Ke Lan Duo as it navigates this leadership transition [7]. - The removal of the founder marks a significant turning point for the company, raising questions about its future direction and strategy in a competitive market [7].

Core Viewpoint - The recent management change at Miaokelando, known as the "first stock of cheese," has raised concerns among investors, particularly following the dismissal of founder and general manager Chai Xiu due to unfulfilled compensation commitments related to a problematic investment [1][5][6]. Group 1: Management Changes - Chai Xiu was removed from her positions as vice chairman, general manager, and legal representative, with Kuai Yulong, the financial director, taking over as the new general manager and legal representative [1][3]. - Chai Xiu's departure marks a significant shift in the company's leadership, transitioning to a "Mengniu era" as Kuai Yulong is associated with the controlling shareholder, Inner Mongolia Mengniu Dairy [3][7]. - Despite her removal, Chai Xiu retains her shareholding in Miaokelando and continues to participate in board decisions [7]. Group 2: Financial Implications - The company announced that the fair value loss from the problematic investment in a merger fund is expected to reduce the net profit attributable to shareholders by approximately 119 million to 127 million yuan for 2025 [6][8]. - The investment in the merger fund, which involved a 100 million yuan commitment, has become a source of financial strain due to the inability of a related party to repay a 700 million yuan loan [5][6]. Group 3: Strategic Direction - With Kuai Yulong's appointment, the company aims to enhance operational efficiency by leveraging Mengniu's resources, including stable and low-cost raw milk supply, which will reduce reliance on imported cheese [11]. - The collaboration with Mengniu is expected to optimize resource allocation in areas such as channel strategy, product matrix, and brand development [11][12]. - The cheese industry in China is still in its educational phase, with low penetration rates compared to liquid milk, indicating a long road ahead for market growth [12].

1月25日晚，"奶酪第一股"妙可蓝多（600882）（SH600882）发布一则重要人事变动：副董事长、总经 理、法定代表人柴琇被免职，财务总监、行政总经理蒯玉龙接棒，成为新任总经理和法定代表人。 在A股市场上，这样的免职公告并不多见，第二天（26日）妙可蓝多盘中最高跌超4%，截至27日收盘 股价，继续下跌2.36%，报22.78元，最新市值为116亿元。 《每日经济新闻》记者注意到，在这则有关任免议案的董事会上，柴琇并未出席，也未参与投票，其任 期原本要到2027年11月。26日，记者曾多次尝试拨打柴琇私人电话并通过微信发送采访提纲，均未获回 复。 在关于妙可蓝多的多篇公开报道中，61岁的柴琇被称为公司创始人，她去年在公开场合也多次代表公司 讲述妙可蓝多的资本故事。就在公司业绩高速增长之时，柴琇黯然离场，失去了经营权。取而代之的则 是来自控股股东内蒙古蒙牛乳业（集团）股份有限公司（以下简称内蒙蒙牛）的高管蒯玉龙，由此妙可 蓝多也全面进入了"蒙牛时代"。 | | | | | | 是否继续在 | 貨 | 是否存在 | | --- | --- | --- | --- | --- | --- | --- | --- ...

当前妙可蓝多正处于战略转型关键期，2026年公司计划从中等规模食品企业迈入大型生产制造企业，去年前三季度，妙可蓝多实现营收39.57亿元，同期归 母净利1.76亿元，增长106.88%。 1月26日，"奶酪第一股"妙可蓝多发布重磅人事公告，原行政总裁蒯玉龙正式接替创始人柴琇出任公司CEO，柴琇被免去副董事长、总经理及法定代表人职 务，任期终止日期较原定的2027年11月提前。 此次人事调整也标志着妙可蓝多结束创始人主导时代，正式迈入少壮派职业经理人带领的专业化经营新阶段。 孙婉秋 摄 柴琇离任的直接导火索为其关联方通过体外并购基金提供的担保债务逾期，债权人为妙可蓝多第一大股东蒙牛，该事件预计导致公司2025年净利润减少1.19 亿至1.27亿元。尽管柴琇曾承诺个人兜底该基金亏损，但未能履行，这也加速了蒙牛系全面接管进程。同日披露的权益变动公告显示，蒙牛于2025年12月29 日至2026年1月23日期间增持133.22万股，持股比例由36.77%升至37.04%，进一步巩固了控股地位。 对于蒯玉龙的接任，市场并不意外，某种意义上，其过往资历和展现出的能力高度契合当前妙可蓝多的发展需求。 进入妙可蓝多之前，蒯玉 ...

Consumption - Dongpeng Beverage has launched its H-share offering with a price not exceeding 248 HKD per share, expecting to end on January 29, and reported revenue exceeding 16.8 billion CNY for the first three quarters [2] - Xibei's founder, Jia Guolong, announced a return to core business focus, abandoning personal branding efforts, as the company faces losses exceeding 600 million CNY [2] - Yanghe Distillery anticipates a net profit decline of over 60% for 2025, primarily due to deep adjustments in the liquor industry and reduced market demand [2] - KFC has slightly raised prices on some delivery items by an average of 0.8 CNY starting January 26, while in-store prices remain unchanged [2] Technology - Jieyue Star has appointed Yin Qi as chairman, responsible for overall strategic direction and technology, and has reportedly completed a multi-billion B+ round of financing [2] - Samsung has raised NAND flash supply prices by 100% in Q1, indicating severe supply-demand imbalance in the semiconductor market [3] - AI chip supplier Aixin Yuanzhi has passed the Hong Kong Stock Exchange hearing [3] Health - Yiling Pharmaceutical expects a net profit of 1.2 to 1.3 billion CNY for 2025, driven by stable market performance in its cardiovascular and respiratory product lines [3] Mobility - Wuxi Xian Dao Intelligent Equipment has passed the Hong Kong Stock Exchange main board listing hearing, with CITIC Securities and JPMorgan as joint sponsors [4] - GAC Group has received nearly 2,000 orders for its GOVY AirCab by the end of 2025 [4] - Ideal Auto plans to close approximately 100 underperforming retail stores in a channel transformation effort [7] Health (Continued) - The first version of the commercial health insurance innovative drug directory took effect on January 1, 2026, aimed at providing more access to innovative drugs through commercial insurance [11] - Nine departments have issued a document encouraging innovative drugs to enter retail pharmacies, aiming to enhance the quality of the pharmaceutical retail industry [13]